The Thoracic Oncology Group of Australasia (TOGA) is the leading collaborative network driving mesothelioma and lung cancer research and clinical trials across Australia and New Zealand.
TOGA brings together national and international experts in thoracic cancer care, and people living with thoracic cancers (lung cancer and mesothelioma) to identify how developing research and unmet need are driving new standards in care.
Together, TOGA designs, secures funding and conducts clinical trials to ensure the translation of research advances through implementing pilot infrastructure, educating healthcare professionals and advocating for PBS and MBS reimbursement.
With a membership drawing from across Australasia, TOGA is able to drive improved thoracic cancer care and research for healthcare professionals in all major Australian hospitals treating thoracic cancer, and people living with thoracic cancers.
Since TOGA’s inception in 2020, we have endorsed 12 research concepts and supproted 38 clinical trials that contribute to improving the outcome and quality of life for thoracic oncology patients. More on TOGA’s Impact
To eliminate thoracic cancers as a source of death, disability and suffering.
To prevent, treat and cure thoracic cancers through research, clinical trials, education and advocacy.
TOGA brings together experts from every part of lung cancer care — prevention, diagnosis, treatment, supportive care, and survivorship. We connect the laboratory, clinic and patient community to research design to the clinic, ensuring clinical and patient needs shape future research.
With strong partnerships across government, industry, and healthcare services, we turn research ideas into real projects that expand treatment options for people with thoracic cancers.
Research only changes lives when it changes practice. TOGA equips healthcare professionals to deliver the latest evidence-based care, through a tailored education program and empowers patients and families to ask about new options.
TOGA is a trusted voice for thoracic cancer. We raise awareness, provide robust evidence to encourage government funding for thoracic cancer research, diagnosis, treatments and services, and work to close the gaps in access and equity of care. Above all, we champion the latest peer-reviewed research so every patient can benefit from the best available treatments.
Courage
To pursue new challenges and novel solutions.
Integrity
To exemplify honesty and trustworthiness in all of our operations.
Equity
To bring an open mind free of prejudice to every interaction and to strive for equal opportunity.
Collaboration
Work with key stakeholders, organisations, and community groups who share our aim of defeating thoracic cancer.
Creativity & Innovation
Strive for and be open to unique and creative solutions.
Our 2025–2028 Strategic Plan sets a bold direction to expand research, grow leadership, and improve care for people with thoracic cancers.
Expand and diversify our research portfolio
Unite members to drive our shared vision
Advance and embed best practice in thoracic cancer care
Amplify TOGA’s position in lung and thoracic cancer
Ensure TOGA’s long-term sustainability and impact
Meet the people driving the TOGA mission, provide scientific excellence, and drive persepctive and advocacy.
The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.
PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198
Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.
Copyright © 2026 TOGA – Thoracic Oncology Group Australasia. No part of this site may be reproduced without our written permission.
